Estimated GFR and risk of hip fracture in older men: comparison of associations using cystatin C and creatinine
- PMID: 23890927
- PMCID: PMC3833961
- DOI: 10.1053/j.ajkd.2013.05.022
Estimated GFR and risk of hip fracture in older men: comparison of associations using cystatin C and creatinine
Abstract
Background: Higher serum cystatin C level is associated with an increased risk of hip fracture in postmenopausal white women, but there is a paucity of data for men. Whether estimated glomerular filtration rate (eGFR) based on cystatin C (eGFRcys) is superior in predicting hip fracture risk to eGFR based on creatinine (eGFRcr) or the combination (eGFR(cr-cys)) also is uncertain.
Study design: Nested case-cohort.
Setting & participants: Participants enrolled in the Osteoporotic Fractures in Men (MrOS) Study (5,994 men aged ≥ 65 years from 6 US centers) including a random subcohort of 1,602 men and 168 men with incident hip fractures (51 of whom were in the subcohort).
Predictor: eGFR(cys), eGFR(cr), and eGFR(cr-cys) computed using the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equations and expressed in categories of <60, 60-74, and ≥ 75 mL/min/1.73 m(2) (referent group).
Outcome: Incident hip fracture ascertained by participant contacts every 4 months and confirmed with radiographic reports.
Results: Median eGFR(cys) was 72.9 (IQR, 60.5-85.7) mL/min/1.73 m(2). In unadjusted models, all measures of eGFR were associated with increased hip fracture risk. However, after adjustment for age, race, site, and body mass index, the association of lower eGFR(cys) (but not lower eGFR(cr) or lower eGFR(cr-cys)) with higher hip fracture risk remained: for <60 versus ≥ 75 mL/min/1.73 m(2), HRs were 1.96 [95% CI, 1.25-3.09], 0.84 [95% CI, 0.52-1.37], and 1.08 [95% CI, 0.66-1.77] for eGFR(cys), eGFR(cr), and eGFR(cr-cys), respectively. Similarly, after adjustment for age, race, site, and body mass index, eGFR < 60 mL/min/1.73 m(2) defined by eGFR(cys), but not eGFR(cr) or eGFR(cr-cys), was associated with higher hip fracture risk. The association between eGFR(cys) and hip fracture was not explained by levels of calciotropic hormones or inflammatory markers, but the relationship was attenuated and no longer reached significance (for <60 vs ≥ 75 mL/min/1.73 m(2): HR, 1.43; 95% CI, 0.88-2.34) after consideration of additional clinical risk factors and bone mineral density.
Limitations: Findings not generalizable to other populations; residual confounding may exist.
Conclusions: Older community-dwelling men with lower eGFR(cys) have an increased risk of hip fracture that is explained in large part by greater burden of risk factors among men with lower eGFR(cys). In contrast, lower eGFR(cr) or lower eGFR(cr-cys) was not associated with a higher age-adjusted hip fracture risk.
Keywords: Kidney function; creatinine; cystatin C; elderly; hip fracture; men.
Published by Elsevier Inc.
Figures

Similar articles
-
Estimated Glomerular Filtration Rate (eGFR) based on cystatin C was associated with increased risk of hip and proximal humerus fractures in women and decreased risk of hip fracture in men, whereas eGFR based on creatinine was not associated with fracture risk in both sexes: The Tromsø Study.Bone. 2021 Jul;148:115960. doi: 10.1016/j.bone.2021.115960. Epub 2021 Apr 14. Bone. 2021. PMID: 33864977
-
Association of Estimated GFR Calculated Using Race-Free Equations With Kidney Failure and Mortality by Black vs Non-Black Race.JAMA. 2022 Jun 21;327(23):2306-2316. doi: 10.1001/jama.2022.8801. JAMA. 2022. PMID: 35667006 Free PMC article.
-
Performance of the 2021 Race-Free CKD-EPI Creatinine- and Cystatin C-Based Estimated GFR Equations Among Kidney Transplant Recipients.Am J Kidney Dis. 2022 Oct;80(4):462-472.e1. doi: 10.1053/j.ajkd.2022.03.014. Epub 2022 May 16. Am J Kidney Dis. 2022. PMID: 35588905
-
Lower serum creatinine to cystatin C ratio associated with increased incidence of frailty in community-dwelling elderly men but not in elderly women.Aging Clin Exp Res. 2024 Jul 4;36(1):140. doi: 10.1007/s40520-024-02787-7. Aging Clin Exp Res. 2024. PMID: 38965150 Free PMC article. Review.
-
Risks of Hip and Nonvertebral Fractures in Patients With CKD G3a-G5D: A Systematic Review and Meta-analysis.Am J Kidney Dis. 2020 Oct;76(4):521-532. doi: 10.1053/j.ajkd.2020.02.450. Epub 2020 Jul 9. Am J Kidney Dis. 2020. PMID: 32654892
Cited by
-
The association between chronic kidney disease, falls, and fractures: a systematic review and meta-analysis.Osteoporos Int. 2020 Jan;31(1):13-29. doi: 10.1007/s00198-019-05190-5. Epub 2019 Nov 12. Osteoporos Int. 2020. PMID: 31720721 Free PMC article.
-
Relationship of High Circulating Cystatin C to Biochemical Markers of Bone Turnover and Bone Mineral Density in Elderly Males with a Chronic Heart Failure.J Med Biochem. 2019 Mar 1;38(1):53-62. doi: 10.2478/jomb-2018-0011. eCollection 2019 Mar. J Med Biochem. 2019. PMID: 30820184 Free PMC article.
-
Evaluation of fracture risk in chronic kidney disease.J Nephrol. 2017 Oct;30(5):653-661. doi: 10.1007/s40620-017-0398-6. Epub 2017 Apr 6. J Nephrol. 2017. PMID: 28386879 Review.
-
Cystatin C and the Risk of Frailty and Mortality in Older Men.J Gerontol A Biol Sci Med Sci. 2017 Jul 1;72(7):965-970. doi: 10.1093/gerona/glw223. J Gerontol A Biol Sci Med Sci. 2017. PMID: 28329858 Free PMC article.
-
Association of Intraindividual Difference in Estimated Glomerular Filtration Rate by Creatinine vs Cystatin C and End-stage Kidney Disease and Mortality.JAMA Netw Open. 2022 Feb 1;5(2):e2148940. doi: 10.1001/jamanetworkopen.2021.48940. JAMA Netw Open. 2022. PMID: 35175342 Free PMC article.
References
-
- Seronie-Vivien S, Delanaye P, Pieroni L, Mariat C, Froissart M, Cristol JP. Cystatin C: current position and future prospects. Clin Chem Lab Med. 2008;46:1664–1686. - PubMed
-
- Fried LF, Biggs ML, Shlipak MG, et al. Association of kidney function with incident hip fracture in older adults. J Am Soc Nephrol. 2007;18:282–286. - PubMed
-
- Dukas L, Schacht E, Stahelin HB. In elderly men and women treated for osteoporosis a low creatinine clearance of <65 ml/min is a risk factor for falls and fractures. Osteoporos Int. 2005;16:1683–1690. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 AR45632/AR/NIAMS NIH HHS/United States
- R01 AG008415/AG/NIA NIH HHS/United States
- U01 AR45647/AR/NIAMS NIH HHS/United States
- U01 AR45614/AR/NIAMS NIH HHS/United States
- U01 AR045654/AR/NIAMS NIH HHS/United States
- U01-AG027810/AG/NIA NIH HHS/United States
- U01 AR045583/AR/NIAMS NIH HHS/United States
- U01 AG042140/AG/NIA NIH HHS/United States
- U01 AR45583/AR/NIAMS NIH HHS/United States
- U01 AR045614/AR/NIAMS NIH HHS/United States
- U01 AR45654/AR/NIAMS NIH HHS/United States
- U01 AR045647/AR/NIAMS NIH HHS/United States
- U01 AR45580/AR/NIAMS NIH HHS/United States
- U01 AG027810/AG/NIA NIH HHS/United States
- AG08415/AG/NIA NIH HHS/United States
- UL1 RR024140/RR/NCRR NIH HHS/United States
- U01 AG18197/AG/NIA NIH HHS/United States
- U01 AG018197/AG/NIA NIH HHS/United States
- U01 AR045580/AR/NIAMS NIH HHS/United States
- U01 AG042139/AG/NIA NIH HHS/United States
- U01 AR066160/AR/NIAMS NIH HHS/United States
- U01 AR045632/AR/NIAMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous